Clinical Trials Directory

We are doing this study to find out if an experimental drug called XmAb819 (the study drug) is a safe and effective treatment for clear cell renal cell carcinoma (ccRCC).

We are doing this study to compare the performance of 2 drugs: zanzalintinib and everolimus. We want to know which option is the most effective for treating neuroendocrine tumors.

If you are in this study, you will fill out an online survey that takes about 30 to 40 minutes. The study team will also collect basic information about you, such as your age and background, along with results from your colonoscopy. This information will be saved in secure research databases. You can choose to give extra samples if you want. These may include a small blood sample taken before your colonoscopy, a stool sample you collect at home using a kit, and extra tissue from your medical procedure. The study team will also review your health records over time to see how you are doing.

We are doing this study to find the safest and most effective dose of an experimental drug called ZL-1310 (the study drug). We want to know if this drug can be beneficial for people with small cell lung cancer (SCLC) that progressed after at least one round of chemotherapy.

We are doing this study to find out if a drug called zolbetuximab, when it is combined with pembrolizumab and standard chemotherapy, is a safe and effective option for treating stomach cancer.